◆ What is information on clinical trials of coronavirus-related drugs ?
"Clinical Trial Information on COVID-19-Related Drugs" provides clinical trial plans for COVID-19-related drugs, their selection and exclusion criteria, and other useful information based on clinical trial information held by the Ministry of Food and Drug Safety.
◆ What data will be opened?
The Ministry of Food and Drug Safety's open data information table displays information on data providers, open data, total number of open data, and provision method. Data provider | open data | Total number of openings | How it's provided |
|---|
| Ministry of Food and Drug Safety | - Information on selection criteria for clinical trial plans for COVID-19-related drugs, information on exclusion criteria for clinical trial plans for COVID-19-related drugs, and information on principal investigators for clinical trial plans for COVID-19-related drugs - Status of domestically approved COVID-19 diagnostic reagents, status of COVID-19 diagnostic reagent production and export, GMP designation approval information for COVID-19 testing devices, and equivalent products and type information for COVID-19 testing-related medical devices. | 2,900 cases | Open API |
◆ How can it be used?
By improving accessibility to COVID-19-related pharmaceutical data through clinical trial information on COVID-19-related drugs, data-driven apps and websites can be utilized for various purposes, such as providing startup information, developing research plans for medical researchers, and supporting the establishment of data-driven clinical trial policies.